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Development	of	a	Label-free	Raman	Imaging	Technique	for	Differentiation	of	Malaria	Parasite	Infected	
from	Non-Infected	Tissue	
	
ABSTRACT:	During	malarial	infection,	the	host	uses	the	spleen	to	clear	the	malaria	parasites,	however,	
the	parasites	have	evolved	the	ability	to	bind	to	endothelial	receptors	in	blood	vessels	of	tissues	to	
avoid	removal,	known	as	sequestration,	and	is	largely	responsible	for	the	symptoms	and	severity	of	
infection.	So	a	technique	which	could	non-invasively	diagnose	tissue	burden	could	be	utilised	as	an	
aid	for	localised	malaria	diagnosis	within	tissue.	Raman	spectroscopy	is	a	label-free	imaging	technique	
and	can	provide	unique	and	chemically	specific	Raman	‘fingerprint’	spectrum	of	biological	samples	
such	as	tissue.	Within	this	study,	Raman	imaging	was	used	to	observe	the	changes	to	the	molecular	
composition	 of	mice	 spleen	 tissue	 under	malarial	 infection,	 compared	with	 non-infected	 samples.	
From	analysis	of	 the	Raman	 imaging	data,	both	 tissue	 types	 showed	very	 similar	 spectral	 profiles,	
which	 highlighted	 that	 their	 biochemical	 compositions	 were	 closely	 linked.	 Principal	 component	
analysis	 showed	 very	 clear	 separation	 of	 the	 two	 sample	 groups,	 with	 an	 associated	 increase	 in	
concentration	of	heme-based	Raman	vibrations	within	the	infected	dataset.	This	was	indicative	of	the	
presence	of	hemozoin,	the	malaria	pigment,	being	detected	within	the	 infected	spleen.	Separation	
also	showed	that	as	 the	hemozoin	content	within	 the	 tissue	 increased,	 there	was	a	corresponding	
change	to	hemoglobin	and	some	lipid/nucleic	acid	vibrations.	These	results	demonstrate	that	Raman	
spectroscopy	can	be	used	to	easily	discriminate	 the	subtle	changes	 in	 tissue	burden	upon	malarial	
infection.			
INTRODUCTION	
Malaria	is	a	mosquito-borne	infectious	disease,	caused	by	the	Plasmodium	parasite1	and	is	a	leading	
cause	of	morbidity	and	mortality	in	the	developing	world.2	Five	species	are	known	to	cause	malaria	
infection	in	humans,	with	Plasmodium	falciparum	(P.	falciparum)	being	responsible	for	a	large	number	
of	cases	in	Africa.1,3		
During	the	erythrocytic	infection	phase,	the	parasite	catabolises	up	to	80	%4	of	the	hosts’	hemoglobin.	
This	 occurs	within	 the	digestive	 vacuole	of	 the	parasite5	 and	produces	 free	heme	as	 a	by-product	
(ferrous	[FeII]	protoporphyrin	IX)6,	which	is	toxic	to	the	parasite.5		To	detoxify	this,	the	parasite	oxidises	
it	to	an	insoluble,	crystalline	material	known	as	hemozoin	or	the	malaria	pigment.5,7	At	the	end	of	the	
erythrocytic	 cycle,	 red	 blood	 cells	 (RBCs)	 rupture,	 releasing	 hemozoin	 and	 parasites	 into	 the	
bloodstream,	with	the	parasites	going	on	to	infect	further	RBCs	and	continue	the	cycle	of	infection.	
While	hemozoin,	under	physiological	conditions,	 is	not	degraded	and	circulates	 in	the	bloodstream	
until	it	is	digested	by	macrophages	present	within	specific	organs.7	The	spleen	is	the	primary	organ	
involved	in	the	development	of	an	immune	response8	during	the	erythrocytic	stage	of	infection	along	
with	 the	elimination	of	parasitised	RBCs	and	hemozoin.9,10	However,	P.	 falciparum	proteins	on	 the	
surface	of	infected	erythrocytes	give	these	cells	the	ability	to	bind	to	endothelial	receptors	in	blood	
vessels	of	tissue,	leading	to	sequestration2,11	of	these	infected	cells	and	hence	reduced	clearance	from	
the	bloodstream.2	 Sequestration	of	parasites	 into	 tissue	 is	 largely	 responsible	 for	 the	 severity	 and	
symptoms	of	 infection12,13,	 therefore,	a	 technique	which	could	non-invasively	detect	 tissue	burden	
would	be	a	great	step	forward.		
Raman	 spectroscopy	 has	 been	 extensively	 used	 for	 the	 identification	 of	 malaria	 infection	 most	
commonly	via	the	detection	of	hemozoin.	It	has	been	widely	reported	by	groups	including	Frosch	et	
al.4	 and	Wood	 et	 al.14	 that	 the	 choice	 of	 Raman	 excitation	wavelength	 is	 key	 to	 gaining	 selective	
enhancement	 of	 hemozoin	 bands	 over	 other	 non-resonant	 cellular	 components.	 Wood	 et	 al.15	
reported	that	by	exploiting	the	resonance	Raman	characteristics	of	hemozoin,	coupled	with	partial	
dark	field	microscopy,	there	was	potential	to	detect	low-pigmented	phases	of	the	malaria	parasite’s	
life-cycle	within	infected	erythrocytes.	More	recently,	Hobro	et	al.16	applied	resonance	Raman	imaging	
to	study	the	progression	of	malaria	infection	via	blood	and	plasma	samples.	They	showed	that	within	
infected	blood	samples,	changes	associated	with	a	loss	of	hemoglobin	and	an	increase	in	hemozoin	
could	be	detected	after	four	days	of	infection.	However,	hemozoin	detection	limits	were	shown	to	be	
reduced	 to	 only	 one	 day,	 following	 Plasmodium	 infection,	 when	 plasma	 samples	 were	 analysed.	
Resonance	Raman	spectroscopy	has	also	been	used	within	a	multimodal	imaging	approach	to	study	
the	disease	mechanisms	of	murine	cerebral	malaria.17	This	work	by	Hackett	et.	al.17	showed	strong	
evidence	 that	 during	 cerebral	malaria	 infection	 iron-mediated	 protein	 oxidation	 occurs	within	 the	
tissue.		
These	studies	highlight	how	valuable	Raman	spectroscopic	techniques	are	for	the	study	of	biological	
matrices	within	malarial	infection.	Because	Raman	spectroscopy	is	a	powerful,	label-free	technique,	it	
can	provide	a	unique	and	chemically	specific	Raman	‘fingerprint’	spectrum	of	biological	samples.18–20	
It	has	a	number	of	advantages	for	studying	these	types	of	materials	including	requiring	minimal	to	no	
sample	preparation18;	being	a	non-destructive	technique21;	and	allowing	specific	chemical	information	
to	be	gained	without	 the	use	of	 stains.22	During	 the	pathogenesis	of	disease,	biological	alterations	
occur,	which	 lead	to	changes	 in	 the	biochemical	composition	of	affected	tissues.	These	changes	 in	
structure,	concentration	and	composition	of	biomolecules	can	be	reflected	in	the	Raman	spectra	of	
tissue	samples.	Indeed,	Raman	spectroscopy	has	been	used	to	study	the	subtle	molecular	changes	in	
tissue	 samples	 associated	 with	 other	 diseases	 including,	 lung23	 cancer;	 breast20,24	 cancer;	 and	
diabetes.18	
In	 this	 work,	 we	 used	 Raman	 spectroscopic	 imaging	 to	 study	 the	 changes	 in	 the	 biochemical	
composition	of	mouse	spleen	tissue	sections	following	infection	with	the	rodent	parasite,	Plasmodium	
berghei	(P.	berghei).	We	compared	the	Raman	spectra	of	infected	with	non-infected	samples	to	detect	
changes	 in	 the	 Raman	 spectral	 signature	 associated	with	 infection.	 The	multivariate	 chemometric	
analysis	technique,	principal	component	analysis	(PCA)	was	applied	to	decompose	the	spectral	data	
into	 components	 and	 attempt	 to	 identify	 subtle	 changes	 to	 biological	 components	 within	 tissue	
sections	which	could	differentiate	infected	tissue	burden	from	non-infected	samples.	
	
MATERIALS	AND	METHODS	
Infections	and	Tissue	Preparation.	Procedures	on	mice	were	approved	following	local	ethical	review	
by	the	University	of	Glasgow	Animal	Procedures	and	Ethics	Committee	and	were	performed	in	strict	
accordance	with	 the	UK	Home	Office	Animals	 (Scientific	Procedures)	Act	1986	 (project	 licence	no.	
P2F28B003).	 Two	 female,	 BALB/c	 mice	 (Harlan,	 Bicester,	 UK;	 6-8	 weeks	 old)	 were	 infected	 with	
asynchronous	P.	berghei	ANKA,	and	euthanised	when	peripheral	blood	parasitemia	reached	5	%.	At	
this	level,	although	high,	the	infection	is	asymptomatic	in	BALB/c	mice.	Spleens	were	removed	from	
these	and	 from	two	uninfected	control	mice	and	embedded	 in	 tissue	 freezing	medium	(Tissue-Tek	
O.C.T.).25	This	freezing	medium	was	used	to	preserve	the	tissue	structure.	Frozen	tissue	blocks	were	
then	positioned	in	a	cryostat	chamber	at	-22°C,	cut	into	sections	with	a	thickness	of	10	µm	and	placed	
on	poly-L-lysine	glass	slides	with	Tissue-Tek	O.C.T.	Ten	tissue	sections	were	taken	from	the	infected	
spleens,	along	with	a	 further	ten	from	the	uninfected	spleens.	Tissue	sections	on	glass	slides	were	
stored	at	-20°C	prior	to	analysis.	Spleen	tissue	was	chosen	as	it	is	a	key	tissue	for	the	sequestration	of	
the	parasite.		
Reference	Spectra.	Synthetic	hemozoin	was	prepared	using	methods	reported	by	Egan	et.	al.26,27	and	
a	2.5	mg/mL	solution	prepared	with	PBS	(10	mM,	pH	7.2).	Hemoglobin	was	purchased	from	Sigma-
Aldrich	and	a	10	mg/mL	solution	prepared	with	PBS.	100	µL	of	each	solution	were	spotted	on	glass	
coverslips	and	allowed	to	dry	overnight.		
Raman	Spectroscopy.	Tissue	sections	were	left	to	thaw	at	room	temperature,	washed	once	with	PBS	
(10mM,	pH	7.2)	and	finally	rinsed	in	d.H2O.	Raman	mapping	was	performed	using	a	Renishaw	inVia	
Raman	spectrometer	equipped	with	532	nm	laser	excitation	(5	%	laser	power,	1	mW)	and	an	1800	
l/mm	grating.	 	Raman	 images	of	uninfected	and	 infected	malaria	tissue	were	recorded	using	a	x50	
objective	(NA	=	0.75)	with	an	 integration	time	of	3	s	per	spectrum,	a	step	size	of	1	µm,	and	in	the	
spectral	range	of	680	–	2330	cm-1.	
Hemoglobin	and	hemozoin	reference	spectra	were	collected	using	a	x20	objective,	30	s	acquisition	
time	per	spectra	and	a	532	nm	laser	excitation	(1	%	laser	power,	0.1	mW).		
Data	Pre-processing.	In	all	datasets,	a	cosmic	ray	removal	algorithm	was	first	applied	within	WiRE	4.2	
software.	This	algorithm	sets	values	for	width	and	height	of	features	to	detect	potential	cosmic	rays,	
which	are	then	accepted	or	rejected	by	the	programmer.	Noise	filtering	was	then	applied	within	the	
same	software,	to	reduce	the	level	of	random	noise	within	the	data	whilst	maintaining	the	important	
Raman	 spectral	 features.	 This	pre-processing	method	applies	 a	 form	of	PCA	 to	 the	dataset,	which	
subsequently	provides	scores	and	loadings	for	each	principle	component	(PC)	to	determine	whether	
components	 primarily	 relate	 to	 real	 Raman	 signals	 or	 noise.	 The	 optimum	 number	 of	 PCs,	 which	
describe	 all	 the	 real	 Raman	 signal	with	minimal	 noise	 interference,	 can	 then	be	 selected	 for	 each	
Raman	map.	Raman	spectra	were	baseline	 corrected	using	an	asymmetric	 least	 square	 smoothing	
algorithm28	 operating	 in	 Matlab	 R2013a	 software	 (The	MathWorks,	 Natick,	 MA,	 USA).	 Finally,	 all	
datasets	were	truncated	so	only	the	fingerprint	region	of	interest	was	studied	(700	–	1700	cm-1).		
The	 reference	 spectra	 shown	are	 the	average	of	 five	 spectra,	 that	were	baselined	using	 the	 same	
asymmetric	least	square	smoothing	algorithm	as	above.		
Empirical	 Analysis.	 In	 this	 study,	 the	 empirical	 analysis	 focused	 on	 the	 ratio	 of	 the	 Raman	 peak	
intensity	at	~745	cm-1	 (v15	hemoglobin)29,30,	 to	 the	peak	 intensity	at	~1307	cm-1	 (v21	hemoglobin	&	
lipids)18,29	for	both	tissue	types.	An	unpaired	student’s	t-test	was	used	to	assess	whether	the	difference	
in	 the	 Raman	 intensity	 ratio	 (I745/I1307)	 between	 non-infected	 and	 infected	 tissues	was	 statistically	
significant.18,19	To	manage	the	data	for	analysis,	all	infected	Raman	maps	were	combined	to	give	one	
large	data	matrix	containing	thousands	of	Raman	spectra,	the	same	process	was	carried	out	with	the	
uninfected	data.	These	were	then	averaged	to	leave	43	final	infected	Raman	spectra	and	43	control	
spectra	 (n	 =	 43).	 These	data	were	 subsequently	used	 for	 empirical	 and	multivariate	 analysis.	 	 The	
intensity	ratios	for	all	samples	were	plotted	to	observe	sample	distribution,	along	with	the	average	
intensity	ratio	plot	for	both	the	control	and	infected	tissue.	This	analysis	was	performed	on	the	same	
data	set,	used	for	the	PCA	model.	
Multivariate	Analysis.	PCA	was	applied	to	highlight	any	spectral	separation	between	the	control	and	
infected	data	sets	using	Matlab	software	version	R2013a	(The	MathWorks,	Natick,	MA,	USA).	Multiple	
maps	for	both	tissue	types	were	combined	and	averaged	to	give	43	final	spectra	for	both	the	control	
and	infected	tissue	data	sets.	The	dataset	was	then	normalised	and	mean	centred	prior	to	PCA	being	
applied.	Principal	component	one	(PC1)	was	then	plotted	against	principal	component	two	(PC2).	The	
loadings	plots	were	also	plotted	 to	determine	correlation.	All	analysis	within	Matlab	software	was	
performed	using	custom	scripts.	
RESULTS	AND	DISCUSSION	
Average	Spectra	of	Non-Infected	and	Malaria	Parasite	Infected	Tissue.	In	this	study	two	approaches	
were	used	to	analyse	the	large	spectral	data	sets.	Firstly,	spectral	features	were	studied	and	changes	
in	relative	peak	intensity	investigated	using	intensity	ratio	maps	and	empirical	analysis.	The	second	
approach	 used	 PCA	 to	 determine	 the	 primary	 spectral	 features	 resulting	 in	 correlations	 or	 anti-
correlation	between	 the	 infected	and	non-infected	 tissue,	by	creating	principal	 components	 to	ex-
plain	the	data	set	variance	in	an	unsupervised	manner.	
Figure	 1A	 shows	 the	 averaged,	 normalised	 Raman	 spectra	 obtained	 from	 a	 non-infected	 (control)	
tissue	map	and	a	P	.berghei	infected	mouse	spleen	tissue	map.	Both	tissue	types	showed	a	very	similar	
spectral	profile,	highlighting	that	the	biochemical	compositions	were	closely	 linked.	Tentative	peak	
assignments	of	 the	Raman	bands	are	 listed	 in	Table	1.	However,	differences	 in	 the	relative	Raman	
peak	 intensities	 for	 infected	 vs.	 control	 tissue	 were	 observed.	 These	 were	 highlighted	 through	
subtraction	of	the	average,	normalised	control	spectra	from	the	infected	(Figure	1B).	This	emphasised	
some	peaks	that	appeared	to	 increase	(~745,	1130,	1170	and	1225	cm-1)	and	decrease	(~1087	and	
1439	cm-1)	in	Raman	signal	intensity	within	the	P.	berghei	infected	tissue	compared	with	the	control.	
This	change	in	relative	peak	intensity	suggests	an	alteration	in	the	biological	composition	of	the	spleen	
at	this	level	of	infection,	characterised	by	changes	in	level	and/or	composition	of	the	biological	species	
assigned	to	these	Raman	signals.		
	Figure	 1.	 Analysis	 of	 Raman	 peak	 intensity	 for	 control	 and	 P.	 berghei-infected	 tissue	 sections.	 (A)	 Averaged,	 normalised	
spectra	from	a	mapped	area	of	control	and	infected	tissue.	Spectra	were	then	normalised	against	the	peak	at	1585	cm-1.	
Tentative	peak	assignments	 are	also	given	 in	 Table	 1.	 (B)	 Subtracted	Raman	 spectrum.	 The	average,	 normalised	 control	
spectrum	was	 subtracted	 from	 the	average,	 normalised	 infected	 spectrum,	both	 shown	 in	 (A),	 to	highlight	any	potential	
biological	components	that	were	being	altered	within	the	malaria	infected	tissue.	(C)	Image	shows	white	light	images	of	both	
tissue	sections,	with	the	grey	box	indicating	the	area	that	was	mapped,	along	with	peak	intensity	ratio	maps	for	selected	
Raman	peaks.	Intensity	ratio	maps	were	created	using	the	peak	intensities	for:	745	cm-1,	1130	cm-1,	1170cm-1,	and	1307	cm-
1	(I745	/	I1307;	I1130	/	I1307;	I1170	/	I1307).	These	ratio	maps	visually	show	relative	changes	in	the	intensity	of	these	Raman	peaks	
within	 the	area	of	P.	berghei-infected	 tissue	 that	was	mapped	compared	 to	 the	uninfected	area.	These	maps	suggest	an	
increase	 or	 alteration	 to	 some	 key	 biological	 components	 within	 the	 infected	 tissue	 including,	 multiple	 hemoglobin	
vibrations29,	lipids31,	and	proteins30.	
Intensity	ratio	maps	(Figure	1C)	were	created	to	visually	show	these	relative	peak	changes,	using	the	
1307	cm-1	peak	as	a	constant	background.	These	heat	intensity	maps	show	a	clear	overall	increase	in	
the	peak	 intensity	 ratios	within	 the	 infected	mapped	areas	compared	 to	 the	control	 samples.	This	
suggests	alterations	to	biological	components	including	hemoglobin29,32	(~745,	1130	and	1170	cm-1),	
lipids30	(~1130	cm-1)	and	other	proteins30	(~1170	cm-1)	at	this	level	of	P.	berghei	infection.	Ratio	maps	
were	also	created	for	different	samples	to	show	this	overall	 increase	was	common	throughout	the	
infected	tissue	(Figure	S1).	Within	these	maps,	for	both	uninfected	and	infected	samples,	particularly	
intense	 regions	 are	 present	 (Figure	 1C	 and	 S1).	 This	 can	 be	 explained	 through	 enhanced	 Raman	
intensity	 from	 resonance	 contributions	 of	 the	 biological	 components	within	 these	 areas	 of	 tissue.		
These	ratio	maps	visually	show	relative	changes	in	biological	peaks	in	a	sample	manner	and	can	be	
used	 alongside	 empirical	 analysis	 and	 PCA	 to	 aid	 in	 classification	 of	 tissue	 types	 from	 Raman	
spectroscopy	data.		
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Table	1.	Tentative	peak	assignments	for	the	main	peaks	observed	in	the	spectral	profile	for	both	non-infected	and	P.	berghei	
infected	spleen	samples.	Raman	Shift	(cm-1)	 Assignmenta	745	 v15	Hb	[v	(pyr	breathing)]	998	 Proteins	(Phe),	v45	Hb	[v(CC)asym]	1087	 DNA	/	Nucleic	acids	[vs	(PO2-),	v	(CC)],	Hb	1130	 Lipids,	v5	Hb	[δ(=CH2)4]	1170	 Proteins	(Tyr),	v30	Hb	[v	(pyr	half	-ring)asym]	1225	 Proteins	(Amide	III),	v13/v42	Hb	[δ(CH)]	1307	 Lipids,	v21	Hb	[δ(CH)]	1338	 Nucleic	acid	modes,	v41	Hb	[v	(pyr	half-ring)sym]	1370	 v4	Hb	[v	(pyr	half-ring)sym]	1396	 CH2	deformation,	v20	Hb	[v	(pyr	quarter-ring)]	1439	 Lipids	[δ(CH2)]	1561	 v11	Hb	[v(CC)]	1585	 v37	Hb	[v(CC)asym]	1618	 v19	Hb	[v(CC)asym]	1636	 Proteins	(Amide	I),	v10	Hb	[v(CC)asym]	
a	Abbreviations:	v	–	stretch	vibration;	δ	–	in-plane	bending	vibration;	sym	–	symmetric;	asym	–	asymmetric;	Hb	–	hemoglobin;	
Phe	–	phenylalanine;	Tyr	–	tyrosine.	Assignments	from	ref.16,18,29–31	
	
Empirical	Analysis	of	Raman	Spectra.	Diagnostic	algorithms	based	on	peak	intensity	ratios	have	been	
widely	employed	in	the	literature	for	tissue	classification	using	Raman	spectroscopy.18,19,23	These	have	
been	shown	to	successfully	correlate	variations	in	tissue	spectra	with	tissue	pathology19	in	a	simple	
manner.	
An	 empirical	 analysis	 based	 on	 the	 peak	 intensity	 ratio	 of	 two	 Raman	 bands	was	 used	 for	 tissue	
classification	within	this	study.	Figure	2A	shows	the	scatter	plot	of	the	ratio	of	Raman	peak	intensity	
at	745	cm-1	to	1307	cm-1	(I745/I1307)	for	the	43	averaged	P.	berghei	infected	samples	and	43	uninfected	
samples.	A	clear	separation	was	observed	in	the	scatter	plot	for	the	two	data	sets,	with	replicate	data	
within	each	tissue	type	being	grouped	closely	together,	indicating	little	intra-sample	variation	in	the	
intensity	ratios.	The	mean	ratio	values	(mean	±	std.	dev.)	for	both	control	(0.903	±	0.015)	and	infected	
(1.119	±	0.021)	data	sets	were	also	plotted	(Figure	2B).	It	was	shown	that	the	differences	between	the	
mean	 ratios	 for	each	 tissue	 type	were	statistically	 relevant	 (unpaired	student’s	 t-test,	p	<	0.0001).	
Infected	tissue	showed	a	higher	 ratio	value	compared	with	control,	 this	could	be	explained	by	 the	
increase	 in	heme-based	Raman	vibrations	 (~745	cm-1	 assigned	 to	v15	Hb29)	due	 to	 the	presence	of	
hemozoin	within	the	infected	samples.		
	Figure	2.	Empirical	analysis	results.	(A)	Scatter	plot	of	peak	intensity	ratios	(I745/	I1307)	for	43	average	Raman	spectra	from	all	
the	control	and	malaria	infected	mice	spleen	tissue	that	were	mapped.	A	clear	separation	of	the	two	data	sets	was	observed,	
with	little	intra-sample	variability.		(B)	Average	intensity	ratio	plots	for	the	control	(0.903	±	0.015)	and	infected	(1.119	±	0.021)	
data	sets.	This	difference	in	mean	ratios	was	shown	to	be	statistically	relevant	(unpaired	Student’s	t-test,	p	<	0.0001).	
From	these	results,	 it	has	been	shown	that	empirical	analysis	of	Raman	spectra	could	be	used	as	a	
simple,	reliable	marker	to	indicate	the	presence	of	infection.	It	has	also	been	shown	that	other	peak	
ratios	can	also	be	used	to	classify	the	two	tissue	types	with	good	results	(Figure	S2).	However,	this	
method	 does	 not	 consider	 the	 entire	 Raman	 spectrum.	 To	 help	 improve	 tissue	 analysis	 and	
classification,	PCA	was	employed	to	highlight	the	most	diagnostically	significant	Raman	peaks.		
	
Principal	Component	Analysis.	PCA	was	used	to	analyse	this	data	set	to	better	distinguish	the	spectral	
differences	between	the	non-infected	and	infected	spleen	tissue.	Figure	3	shows	the	scores	plot	for	
PC1	(97.6	%	variance)	and	PC2	(1.45	%	variance),	along	with	the	corresponding	loadings	vectors.	As	
can	be	seen	from	the	scores	plot	(Figure	3A)	PC1	is	primarily	responsible	for	the	separation	of	the	two	
tissue	types.	The	loadings	plot	(Figure	3B)	for	PC1	indicates	that	the	peaks	in	the	negative	half	of	the	
plot	are	spectrally	important	for	describing	the	separation	of	the	infected	tissue	(~750,	1130,	1170,	
1225,	1370,	1529,	1588	and	1628	cm-1),	with	the	latter	few	being	more	indicative	of	hemozoin	than	
hemoglobin.	 The	 negative	 peaks	 at	 ~1529,	 1588	 and	 1628	 cm-1	 match	 closely	 with	 that	 of	 the	
hemozoin	reference	spectra	in	Figure	4	(core	structures	of	hemoglobin	and	hemozoin	shown	in	Figure	
S4	 to	 highlight	 structural	 similarities)	 and	 therefore	 suggest	 detection	 of	 the	 insoluble	 pigment	
through	Raman.	The	negative	~1370	cm-1	peak	 is	present	 in	both	reference	spectra;	however,	 it	 is	
much	more	prominent	within	hemozoin	and	so	suggest	that	hemozoin	is	contributing	to	this	peaks	
appearance	within	 the	 PC1	 loadings	 plot.	 It	 is	 well	 known	 that	 hemozoin	 accumulates	within	 the	
spleen8,9,	therefore	it	follows	that	there	will	be	an	associated	increase	in	concentration	of	heme-based	
Raman	 vibrations.	 This	 is	 clearly	 shown	 in	 this	 PCA	model	 as	many	 of	 these	 peaks	 separating	 the	
infected	tissue	from	the	uninfected	samples	can	be	assigned	to	heme-vibrations,	including	hemozoin.	
Although	other	proteins	and	 lipids	will	be	present	and	exhibit	Raman	bands	 in	 similar	positions	 to	
those	of	hemoglobin	(~1130,	1170,	1225	&	1396	cm-1),	resonance	effects	would	mean	hemoglobin	will	
tend	to	dominate	the	spectra	(excitation	in	the	regions	of	Q-absorption	bands)29,32,33,	with	the	other	
proteins	and	lipids	having	only	small	contributions	to	the	observed	spectra.		
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Within	the	positive	peaks	in	PC1	loadings	plot,	the	relatively	broad	~1087	cm-1	peak	is	likely	to	have	a	
significant	contribution	 from	hemoglobin	 (Figure	4),	however,	 its	broadness	suggests	contributions	
from	 other	 components.	 Raman	 bands	 within	 this	 region	 can	 also	 be	 assigned	 to	 C-C	 and	 O-P-O	
vibrations	of	nucleic	acids.18,30	The	other	prominent	positive	peak	at	~1439	cm-1	can	mainly	be	assigned	
to	Raman	vibrations	from	lipids18,31,	although	it	may	also	have	slight	hemoglobin	contributions	(~1432	
cm-1	peak	in	reference	spectra).	Analysis	of	PC1	loadings	plot	indicates	that	at	this	level	of	P.	berghei	
malaria	infection	Raman	spectroscopy	can	clearly	detect	hemozoin	accumulation	within	the	spleen,	
with	the	positive	peaks	(~1087	and	1439	cm-1)	indicating	that	as	the	amount	of	hemozoin	increases	
within	 the	 spleen	 there	 is	 a	 corresponding	 change	 to	 hemoglobin	 and	 some	 lipids/nucleic	 acid	
vibrations.		
	
Figure	3.	PCA	plot	for	control	and	malaria	infected	samples	from	mouse	spleen	tissue	sections.	(A)	Scores	plot	showing	very	
clear	separation	of	 the	control	 (green)	and	 infected	(blue)	data	sets.	Separation	 is	occurring	mainly	along	PC1,	with	 little	
separation	along	PC2.	(B)	Loadings	plots	for	PC1	and	PC2,	with	the	main	peaks	in	both	indicated.	The	peaks	in	the	negative	
half	of	PC1	are	responsible	for	the	separation	of	the	infected	samples	along	PC1	away	from	the	control	samples.	
PC2	describes	little	separation	between	the	control	and	infected	samples.	From	the	PC2	loadings	plot	
(Figure	3B)	the	positive	peaks	(~1550,	1568,	1601	cm-1)	originate	mainly	from	hemoglobin	vibrations,	
whereas	the	negative	peaks	have	contributions	from	hemoglobin	as	well	as	from	other	proteins18,30	
(~1170,	1225	and	1636	cm-1)	and	lipids31	(~1127	cm-1).	This	PCA	analysis	indicates	that	Raman	imaging	
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can	easily	distinguish	between	P.	berghei	 infected	spleen	 tissue	 from	uninfected	samples,	 through	
identification	of	hemozoin	accumulation	and	alterations	to	other	key	biological	components.		
	
Figure	4:	Raman	reference	spectra	of	hemoglobin	and	hemozoin.	The	spectra	shown	are	the	average	of	five	spectra	and	have	
been	baseline	corrected,	normalised	to	the	highest	peak	and	offset	for	clarity.	Key	Raman	bands	are	also	indicated.		
CONCLUSIONS	
In	 conclusion,	 a	 combination	 of	 Raman	 imaging	 with	 multivariate	 analysis	 resulted	 in	 very	 clear	
discrimination	 of	P.	 berghei	 infected	 tissue	 from	 non-infected	 samples.	 Separation	 highlighted	 an	
overall	increase	in	heme-based	Raman	vibrations	within	the	infected	samples,	which	correlates	with	
the	accumulation	of	hemozoin	within	the	spleen	contributing	to	this.	Hemozoin	detection	was	clear	
with	the	identification	of	key	peaks	occurring	~1370,	1529,	1588,	and	1628	cm-1	which	matched	closely	
with	the	reference	spectra.	Chemometric	analysis	also	showed	that	at	the	level	of	P.	berghei	infection	
reported	here,	changes	to	hemoglobin	and	some	other	lipid/nucleic	acid	vibrations	corresponded	with	
an	increase	in	hemozoin	content	within	the	spleen.	Other	proteins	(tyrosine	~1130	cm-1,	and	Amide	III	
~1225	cm-1)	and	lipids	(~1130	cm-1)	were	also	contributing	to	the	separation	of	infected	tissue	from	
control.	 However,	 due	 to	 the	 resonance	 effects	 of	 heme-based	 compounds	 the	 separation	
contribution	from	these	biological	components	would	have	been	small.		
The	 use	 of	 peak	 ratio	 maps	 and	 empirical	 analysis	 also	 highlighted	 changes	 to	 the	 biological	
components	as	you	move	towards	an	infected	tissue	state.	These	two	simple	data	analysis	methods	
could	be	used	in	combination	with	the	PCA	to	help	improve	efficiency	of	Raman	tissue	analysis	and	
classification.		
As	the	Raman	imaging	technique	used	in	this	study	had	a	short	penetration	depth,	it	would	not	be	
suitable	 for	 in	 vivo	 diagnostics.	 However,	 with	 the	 development	 of	 spatially	 offset	 Raman	
spectroscopy,	which	allows	accurate	analysis	through	millimetres	of	material	when	obscuring	barriers	
such	as	skin	are	present34,35,	this	may	allow	for	biochemical	information	from	tissue	to	be	detected	in	
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vivo	in	the	near	future.	Overall,	this	approach	demonstrates	the	potential	use	of	Raman	spectroscopy	
to	provide	detailed	chemical	information	from	both	malaria	parasite	infected	and	control	tissue	and	
when	coupled	with	PCA,	discrimination	due	to	infection	burden	is	achievable	between	the	two	sample	
groups.		 	
(1)		 World	Health	Organisation.	World	Malaria	Report	2015;	2015.	
(2)		 Aird,	W.	C.;	Mosnier,	L.	O.;	Fairhurst,	R.	M.	Blood	2014,	123	(2),	163–168.	
(3)		 CDC:	Malaria	Parasites	https://www.cdc.gov/malaria/about/biology/parasites.html	(accessed	
Sep	22,	2017).	
(4)		 Frosch,	T.;	Koncarevic,	S.;	Becker,	K.;	Popp,	J.	Analyst	2009,	134	(6),	1126–1132.	
(5)		 Coronado,	L.	M.;	Nadovich,	C.	T.;	Spadafora,	C.	Biochim.	Biophys.	Acta	2014,	1840	(6),	2032–
2041.	
(6)		 Frosch,	T.;	Koncarevic,	S.;	Zedler,	L.;	Schmitt,	M.;	Schenzel,	K.;	Becker,	K.;	Popp,	J.	J.	Phys.	
Chem.	B	2007,	111,	11047–11056.	
(7)		 Boura,	M.;	Frita,	R.;	Góis,	A.;	Carvalho,	T.;	Hänscheid,	T.	Trends	Parasitol.	2013,	29	(10),	469–
476.	
(8)		 Ferrer,	M.;	Martin-Jaular,	L.;	De	Niz,	M.;	Khan,	S.	M.;	Janse,	C.	J.;	Calvo,	M.;	Heussler,	V.;	Del	
Portillo,	H.	a.	Parasitol.	Int.	2014,	63	(1),	195–205.	
(9)		 Del	Portillo,	H.	A.;	Ferrer,	M.;	Brugat,	T.;	Martin-Jaular,	L.;	Langhorne,	J.;	Lacerda,	M.	V.	G.	
Cell.	Microbiol.	2012,	14	(3),	343–355.	
(10)		 Engwerda,	C.	R.;	Beattie,	L.;	Amante,	F.	H.	Trends	Parasitol.	2005,	21	(2),	75–80.	
(11)		 Franke-Fayard,	B.;	Fonager,	J.;	Braks,	A.;	Khan,	S.	M.;	Janse,	C.	J.	PLoS	Pathog.	2010,	6	(9).	
(12)		 Autino,	B.;	Corbett,	Y.;	Castelli,	F.;	Taramelli,	D.	Mediterr.	J.	Hematol.	Infect.	Dis.	2012,	4	(1).	
(13)		 Khoury,	D.	S.;	Cromer,	D.;	Best,	S.	E.;	James,	K.	R.;	Kim,	P.	S.;	Engwerda,	C.	R.;	Haque,	A.;	
Davenport,	M.	P.	Infect.	Immun.	2014,	82	(1),	212–220.	
(14)		 Wood,	B.	R.;	Langford,	S.	J.;	Cooke,	B.	M.;	Glenister,	F.	K.;	Lim,	J.;	McNaughton,	D.	FEBS	Lett.	
2003,	554	(3),	247–252.	
(15)		 Wood,	B.	R.;	Hermelink,	A.;	Lasch,	P.;	Bambery,	K.	R.;	Webster,	G.	T.;	Khiavi,	M.	A.;	Cooke,	B.	
M.;	Deed,	S.;	Naumann,	D.;	McNaughton,	D.	Analyst	2009,	134	(6),	1119–1125.	
(16)		 Hobro,	A.	J.;	Konishi,	A.;	Coban,	C.;	Smith,	N.	I.	Analyst	2013,	138	(14),	3927–3933.	
(17)		 Hackett,	M.	J.;	Aitken,	J.	B.;	El-Assaad,	F.;	McQuillan,	J.	a;	Carter,	E.	a;	Ball,	H.	J.;	Tobin,	M.	J.;	
Paterson,	D.;	de	Jonge,	M.	D.;	Siegele,	R.;	Cohen,	D.	D.;	Vogt,	S.;	Grau,	G.	E.;	Hunt,	N.	H.;	Lay,	
P.	a.	Sci.	Adv.	2015,	1	(11),	1–13.	
(18)		 Kochan,	K.;	Marzec,	K.	M.;	Chruszcz-Lipska,	K.;	Jasztal,	A.;	Maslak,	E.;	Musiolik,	H.;	Chłopicki,	
S.;	Baranska,	M.	Analyst	2013,	138	(14),	3885–3890.	
(19)		 Teh,	S.	K.;	Zheng,	W.;	Ho,	K.	Y.;	Teh,	M.;	Yeoh,	K.	G.;	Huang,	Z.	Br.	J.	Cancer	2008,	98	(2),	457–
465.	
(20)		 Frank,	C.	J.;	McCreery,	R.	L.;	Redd,	D.	C.	Anal.	Chem.	1995,	67	(5),	777–783.	
(21)		 Huser,	T.;	Chan,	J.	Adv.	Drug	Deliv.	Rev.	2015,	89,	57–70.	
(22)		 Hobro,	A.	J.;	Pavillon,	N.;	Fujita,	K.;	Ozkan,	M.;	Coban,	C.;	Smith,	N.	I.	Analyst	2015,	140,	2350–
2359.	
(23)		 Huang,	Z.;	McWilliams,	A.;	Lui,	H.;	McLean,	D.	I.;	Lam,	S.;	Zeng,	H.	Int.	J.	cancer	2003,	107	(6),	
1047–1052.	
(24)		 Haka,	A.	S.;	Shafer-Peltier,	K.	E.;	Fitzmaurice,	M.;	Crowe,	J.;	Dasari,	R.	R.;	Feld,	M.	S.	Proc.	Natl.	
Acad.	Sci.	U.	S.	A.	2005,	102	(35),	12371–12376.	
(25)		 Tissue-Tek	O.C.T	Compound	and	Cryomolds	http://www.sakura.eu/Our-
products/item/11/Cryotomy/48/Tissue-Tek-OCT-Compound-and-Cryomolds	(accessed	Sep	
15,	2017).	
(26)		 Egan,	T.	J.;	Rossa,	D.	C.;	Adamsb,	P.	A.	FEBS	Lett.	1994,	352,	54–57.	
(27)		 Egan,	T.	J.;	Mavuso,	W.	W.;	Ncokazi,	K.	K.	Biochemistry	2001,	40	(1),	204–213.	
(28)		 Eilers,	P.	H.	C.;	Boelens,	H.	F.	M.	Life	Sci.	2005,	1–26.	
(29)		 Rusciano,	G.;	De	Luca,	A.	C.;	Pesce,	G.;	Sasso,	A.	Sensors	2008,	8	(12),	7818–7832.	
(30)		 Movasaghi,	Z.;	Rehman,	S.;	Rehman,	I.	U.	Appl.	Spectrosc.	Rev.	2007,	42	(5),	493–541.	
(31)		 Krafft,	C.;	Codrich,	D.;	Pelizzo,	G.;	Sergo,	V.	Analyst	2008,	133	(3),	361–371.	
(32)		 Polakovs,	M.;	Mironova-Ulmane,	N.;	Kurjane,	N.;	Reinholds,	E.;	Grube,	M.	Proc.	SPIE	2008,	
7142,	714214.1-714214.8.	
(33)		 Spiro,	T.	G.;	Strekas,	T.	C.	J.	Am.	Chem.	Soc.	1974,	96	(2),	338–345.	
(34)		 Stone,	N.;	Matousek,	P.	Cancer	Res.	2008,	68	(11),	4424–4430.	
(35)		 Keller,	M.	D.;	Majumder,	S.	K.;	Mahadevan-Jansen,	A.	Opt.	Lett.	2009,	34	(7),	926–928.	
	
